Selling Your Galectin Therapeutics Inc (NASDAQ: GALT) Stock? Here’s What You Need To Know

Galectin Therapeutics Inc (NASDAQ:GALT) price on Thursday, July 03, rose 0.46% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.18.

A look at the stock’s price movement, the close in the last trading session was $2.17, moving within a range at $2.125 and $2.245. The beta value (5-Year monthly) was 0.545. Turning to its 52-week performance, $3.90 and $0.73 were the 52-week high and 52-week low respectively. Overall, GALT moved 68.99% over the past month.

Galectin Therapeutics Inc’s market cap currently stands at around $137.97 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-15.

Turning to the stock’s technical picture we see that short term indicators suggest on average that GALT is a 100% Buy. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.

GALT’s current price about 9.91% and 37.14% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 56.30, while 7-day volatility ratio is 11.90% and 20.16% in the 30-day chart. Further, Galectin Therapeutics Inc (GALT) has a beta value of 0.78.

If we refocus on Galectin Therapeutics Inc (NASDAQ:GALT), historical trading data shows that trading volumes averaged 1.0 over the past 10 days and 583.22K over the past 3 months. The company’s latest data on shares outstanding shows there are 63.29 million shares.

The 31.40% of Galectin Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 15.75% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 8.95 million on 2025-06-13, giving us a short ratio of 56.27. The data shows that as of 2025-06-13 short interest in Galectin Therapeutics Inc (GALT) stood at 2374.0 of shares outstanding, with shares short rising to 8.67 million registered in 2025-05-15. Current price change has pushed the stock -7.23% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GALT stock continues to rise going into the next quarter.

Stocks Register
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.